Cannabix Technologies Provides Update on Marijuana Breathalyzer Development

VANCOUVER, British Columbia, April 17, 2019  -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that recent characterization work with Cannabix’s FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device with human subjects has shown the ability to consistently discriminate unwanted ions from complex human breath background matrices allowing for THC (∆9-tetrahydrocannabinol) detection.  In particular, recent testing with updated FAIMS cell geometries has shown the ability to consistently supress several compounds that are commonly found in breath like nicotine, garlic, onion, meats, ethanol, and volatile flavorants such as methyl salicylate and menthol (commonly found in gum) allowing for discrimination and mobility of THC in exhaled breath.
Read more: Cannabix Technologies Inc ( BLO )

Lotus Ventures Obtains Cannabis Act Licenses from Health Canada

VANCOUVER, March 11, 2019 / - Lotus Ventures Inc. (the "Company" or "Lotus") (CSE: J) (Frankfurt: LV9) is pleased to announce that it has obtained a "Standard Cultivation" licence and a "Sale for Medical Purposes" licence pursuant to the Cannabis Act and Cannabis Regulations. The licences give Lotus the ability to begin cultivation at its fully constructed 22,500 square-foot, indoor, purpose-built facility in Armstrong, British Columbia.
Read more: Lotus Ventures Inc ( J )

Pure Global Cannabis Awarded Health Canada Sales License

TORONTO, Jan. 11, 2019 - Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the "Company" or "Pure Global") an integrated, growth-oriented life sciences and consumer products cannabis company, through its subsidiary PureSinse Inc. ("PureSinse"), is excited to announce that Health Canada has issued PureSinse a Sales License under the Cannabis Act.
 
Eligible and pre-registered Canadian medical patients can soon select from two dozen premium cannabis products offered by PureSinse, via its newly launched eCommerce website at PureSinse.com. The Company is committed to supporting medical cannabis patients by emphasizing the quality of and access to the products they need. The Company anticipates growing to 70 SKUs (stock-keeping units) by mid-2019, including adding extracted oil products, and vape pens.
Read more: Pure Global Cannabis ( PURE )

Ovation Science Inc. Closes $2,415,000 IPO and is Listed

Vancouver, British Columbia--(November 15, 2018) - Ovation Science Inc. (CSE: OVAT) ("Ovation" or the "Company") announces that it has closed its Initial Public Offering of units at $0.30 per unit (the "Units") pursuant to its final prospectus dated October 26, 2018 (the "Prospectus"). Each Unit consists of one common share and one half of a non-transferable share purchase warrant (the "Warrants") with each whole Warrant entitling the holder to purchase one additional common share of the Company at a price of $0.45 per common share for a period of two years from closing of the Offering (the "Expiry Date") subject to the Company's right to accelerate the Expiry Date on written notice to the holders of Warrants (the "Acceleration Notice") to accelerate the Expiry Date to the date that is 20 days from the date of the Acceleration Notice provided that the volume weighted average closing price of the Company's Common Shares on the Canadian Securities Exchange is $0.65 or more for 10 consecutive trading days.
Read more: Ovation Science Inc ( OVAT )

The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety

VANCOUVER, British Columbia, Nov. 15, 2018 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased report that it has engaged a leading B.C. based engineering and design firm for the development of a handheld breath collection device for its marijuana breathalyzer unit. MistyWest Engineering of Vancouver has begun work on a portable handheld device that will provide for easy collection of breath samples at the point of care.
 
MistyWest is a highly regarded engineering and design firm that has worked on several high profile and innovative product development projects in North America –demonstrating the ability to complete projects rapidly. Cannabix will use the new handheld unit for the collection of multiple samples from many users under a variety of conditions, quickly. 
Read more: Cannabix Technologies ( BLO )

Videos / Webinars

View all videos